Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,719 public trials 5,051 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT07365306

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +16 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Atlanta Cancer Center Newnan, Georgia, United States
  • City of Hope at Chicago Zion, Illinois, United States
View Trial Details
Recruiting

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

NCT07589634

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Ampang Ampang, Malaysia
  • Beverly Hills Cancer Center (BHCC) Beverly Hills, California, United States
  • Hospital Sultanah Aminah Johor Bharu, Malaysia
  • Sarawak General Hospital Kuching, Malaysia
View Trial Details
Recruiting

HLA Demographics Study in Adults With Type 1 Diabetes

NCT06860516

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • University of Florida- Gainesville Gainesville, Florida, United States
  • Joslin Diabetes Center Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Recruiting

Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

NCT06648889

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University Hospital Augsburg, II. Medizinischen Klinik, Hämatologie, internistische Onkologie und Hämostaseologie Augsburg, Germany
  • Charité Berlin, Campus Benjamin Franklin, Department of Hematology, Oncology and Tumorimmunologyt Hämatologie Berlin, Germany
  • Gesundheit Nord Klinikverbund Bremen gGmbH, Klinikum Bremen-Mitte, Med. Klinik I Bremen, Germany
  • Klinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I Dresden, Germany
View all 15 locations
View Trial Details
Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT07518186

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
View all 151 locations
View Trial Details
Recruiting

A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT05160584

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • LKH Leoben Leoben, Austria
  • Krankenhaus der barmherzigen Schwestern Vienna, Austria
  • UZ Antwerpen Edegem, Belgium
  • Ziekenhuis Oost-Limburg Genk, Belgium
View all 90 locations
View Trial Details
Recruiting

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT05327114

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • IMMUNOe Health and Research Centers Centennial, Colorado, United States
  • Healthcare Innovations Institute Inc Coral Springs, Florida, United States
  • Neurology Associates PA Maitland, Florida, United States
  • ALS Center at the University of Miami Miami, Florida, United States
View all 120 locations
View Trial Details

Related conditions